Drawing for NETWORK BIO

USPTO serial 50054658

NETWORK BIO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with NETWORK BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alyssa M. Worsham

650 Page Mill RoadWilson Sonsini Goodrich & RosatiPalo Alto, CA 94304

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic preparations, reagents, and assays for testing of body fluids; Medical diagnostic test kits consisting primarily of preparations, reagents, and assays for testing of body fluids; Pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, hematological, oncological, and viral diseases and disordersACTIVE—
009Downloadable computer software for creating and deploying biomedical AI models that generalize across disease and modality; Downloadable computer software for collecting, storing, organizing, analyzing, and interpreting biomedical data to provide clinical insights; Downloadable computer software for use in medical diagnosis, medical treatment, drug discovery, biomarker identification, patient recruiting for clinical trials, and precision medicine research; Downloadable computer software for use in evaluating the effectiveness of medical treatments; Downloadable computer software using artificial intelligence software for biomedical, genomic, and clinical data analysis; Downloadable computer software using artificial intelligence software for clinical informatics and biomedical data warehousing; Downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Downloadable computer software for training and simulating artificial intelligence models; Downloadable computer software for application and database integration; Downloadable computer software for use as an application programming interface (API); Downloadable computer software for natural language processing, generation, understanding, reasoning, and analysisACTIVE—
035Recruiting patients for participation in clinical trials for the testing of drugs; Providing referrals of subjects for enrollment in clinical trials; Business consulting and management in the field of clinical trials and decentralized clinical trials; Providing technical consulting services in the field of marketing and advertising for clinical trials; Verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment for clinical trials; Processing business documents relating to clinical trials; Information management services, namely, clinical data management to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approvalACTIVE—
036Financial services, namely, capital investment in biobanking and biomedical data infrastructureACTIVE—
042Software as a service (SaaS) services featuring software for creating and deploying biomedical AI models that generalize across disease and modality; Software as a service (SaaS) services featuring software for collecting, storing, organizing, analyzing, and interpreting biomedical data to provide clinical insights; Software as a service (SaaS) services featuring software for use in medical diagnosis, medical treatment, drug discovery, biomarker identification, patient recruiting for clinical trials, and precision medicine research; Software as a service (SaaS) services featuring software for use in evaluating the effectiveness of medical treatments; Software as a service (SaaS) services featuring artificial intelligence software for biomedical, genomic, and clinical data analysis; Software as a service (SaaS) services featuring artificial intelligence software for clinical informatics and biomedical data warehousing; Software as a service (SaaS) services featuring software for analyzing health information in support of making clinical decisions in the medical field; Software as a service (SaaS) services featuring software for training and simulating artificial intelligence models; Software as a service (SaaS) services featuring software for application and database integration; Software as a service (SaaS) services featuring software for use as an application programming interface (API); Software as a service (SaaS) services featuring software for natural language processing, generation, understanding, reasoning, and analysis; Research and development services in the fields of computational biology, predictive analytics, artificial intelligence, computer science, multi-modal computer natural language processing, machine learning, and computer software design and development; Research, design and development of computer software; Medical research services; Medical and scientific research in the fields of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, hematological, oncological, and viral diseases and disorders; Pharmaceutical research and development services; Conducting clinical trials for others; Advisory and consultancy services relating to the aforesaidACTIVE—
044Medical diagnostic testing services; Medical laboratory testing services to patients for diagnostic and treatment purposes; Providing clinical medical information relating to clinical services; Advisory and consultancy services relating to the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 17, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 17, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance